How to Start Methotrexate: Initiation, Titration, and Side Effects
Start methotrexate at 10-15 mg weekly as a single oral dose in healthy adults, with mandatory baseline blood work (CBC, liver enzymes, creatinine clearance, chest X-ray) and folic acid supplementation of at least 5 mg weekly. 1, 2
Pre-Treatment Assessment
Before prescribing methotrexate, obtain the following mandatory baseline tests 1, 2:
- Complete blood count with differential and platelets
- Liver function tests (transaminases, albumin)
- Renal function: serum creatinine with calculated creatinine clearance
- Chest X-ray
- Hepatitis B and C serologies (recommended)
- Pregnancy test in women of childbearing age
Additional testing if respiratory history or symptoms present:
- Pulmonary function tests with DLCO measurement 2
Starting Dose and Route
Initial dosing:
- Start at 10-15 mg weekly in healthy adults 1, 2
- Consider 2.5-5 mg weekly in patients with renal impairment 1
- Never prescribe daily dosing - this is a common fatal error 3
Route selection:
- Begin with oral administration 2
- Switch to subcutaneous/intramuscular if: 4, 1
- Gastrointestinal intolerance develops
- Poor compliance
- Inadequate effectiveness (parenteral has higher bioavailability)
Titration Protocol
Dose escalation strategy:
- Increase dose at 6-week intervals if inadequate response 2
- Titrate up to 20-25 mg weekly maximum for rheumatologic conditions 1, 2
- Therapeutic benefit may not appear for 3-12 weeks 1
- If minimal efficacy after 12-16 weeks at optimal dose, consider switching medications 1
Mandatory Folic Acid Supplementation
All patients require folic acid to reduce toxicity 1, 2:
- Minimum 5 mg once weekly
- Take on a different day than methotrexate
- This reduces gastrointestinal and hematologic side effects without compromising efficacy
Monitoring Schedule
Intensive initial monitoring 1, 2:
- Every 7-14 days for first month: CBC, liver enzymes, creatinine
- Every 2-3 months thereafter once stable: same tests
- Every 1-2 months during dose adjustments or high-risk periods
For psoriasis patients specifically 1:
- Monitor serum PIIINP (procollagen III peptide) every 3 months
- Refer for specialist assessment if PIIINP >8 mg/L on two occasions, or three measurements >4.2 mg/L in 12 months, or >10 mg/L once
Common Side Effects
Most frequent adverse reactions 3, 5:
Gastrointestinal (most common):
- Nausea, vomiting, abdominal distress
- Ulcerative stomatitis
- Diarrhea
- Management: switch to parenteral route, ensure folic acid supplementation
Hematologic:
- Leukopenia, thrombocytopenia, anemia
- Dose-related and reversible if caught early
- Requires immediate dose reduction or discontinuation
Hepatotoxicity:
- Transient liver enzyme elevations (common, usually not concerning)
- Persistent abnormalities warrant evaluation
- Chronic fibrosis/cirrhosis with prolonged use
Pulmonary (serious but less common):
- Interstitial pneumonitis, pulmonary fibrosis
- Can be fatal if not recognized early 3
- Presents as cough, dyspnea, fever
Other common effects:
- Malaise, fatigue
- Alopecia
- Photosensitivity
- Increased infection risk
Critical Safety Warnings
Patients must seek urgent medical attention for 1:
- Fever or flu-like illness
- Mouth ulceration
- Unexplained bruising or bleeding
- Severe fatigue
- Nausea, vomiting, abdominal pain, dark urine
- New cough or breathlessness
Absolute requirements:
- Effective contraception in both men and women of reproductive age 1, 3
- Limit alcohol intake (increases hepatotoxicity risk) 1
- Avoid NSAIDs with high-dose methotrexate (can cause fatal toxicity) 3
- Caution with lower doses and NSAIDs - monitor closely 3
Drug Interactions to Avoid
High-risk combinations 3:
- NSAIDs (especially with high doses) - reduce tubular secretion, increase toxicity
- Probenecid - decreases renal clearance
- Trimethoprim-sulfamethoxazole - additive folate antagonism
- Salicylates, phenytoin, sulfonamides - displace from protein binding
Vaccinations
Before starting methotrexate 4, 1:
- Pneumococcal vaccine
- Annual influenza vaccination
- Complete other recommended vaccinations before immunosuppression begins
Common Pitfall
The most dangerous error is daily dosing instead of weekly dosing - this has led to multiple fatalities. Prescriptions should clearly state "ONCE WEEKLY" and never be written PRN 1, 3. Both prescriber and pharmacist must emphasize weekly dosing to patients.